Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-analysis

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 11, 2015, Pages 1907-1918

  Shiota, Seiji ^a   Singh, Siddharth ^b   Anshasi, Ashraf ^a   El Serag, Hashem B ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Barrett's Esophagus; Meta analysis; Prevalence; Risk Factors; Systematic Review

Indexed keywords

ARTICLE; ASIA; BARRETT ESOPHAGUS; CANCER GROWTH; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPLASIA; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; HIATUS HERNIA; HISTOLOGY; HUMAN; PREVALENCE; REFLUX ESOPHAGITIS; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTEMATIC REVIEW; TREND STUDY; ADULT; FEMALE; MALE; META ANALYSIS; MIDDLE AGED;

ADULT; ASIA; BARRETT ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84944277343     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.07.050     Document Type: Article

References (90)

1. Wang K.K., Sampliner R.E. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008, 103:788-797. Practice Parameters Committee of the American College of Gastroenterology.
2. Fitzgerald R.C., di Pietro M., Ragunath K., et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut 2014, 63:7-42.
3. Shimoyama S., Ogawa T., Toma T., et al. A substantial incidence of silent short segment endoscopically suspected esophageal metaplasia in an adult Japanese primary care practice. World J Gastrointest Endosc 2012, 4:38-44.
4. Shaheen N.J., Richter J.E. Barrett's oesophagus. Lancet 2009, 373:850-861.
5. Hvid-Jensen F., Pedersen L., Drewes A.M., et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011, 365:1375-1383.
6. van Soest E.M., Dieleman J.P., Siersema P.D., et al. Increasing incidence of Barrett's oesophagus in the general population. Gut 2005, 54:1062-1066.
7. Bollschweiler E., Wolfgarten E., Gutschow C., et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001, 92:549-555.
8. El-Serag H.B. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007, 5:17-26.
9. Jung H.K. Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil 2011, 17:14-27.
10. El-Serag H.B., Sweet S., Winchester C.C., et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014, 63:871-880.
11. Wong W.M., Lam S.K., Hui W.M., et al. Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese: prevalence and spectrum of the disease. Aliment Pharmacol Ther 2002, 16:2037-2042.
12. Akiyama T., Inamori M., Akimoto K., et al. Risk factors for the progression of endoscopic Barrett's epithelium in Japan: a multivariate analysis based on the Prague C & M Criteria. Dig Dis Sci 2009, 54:1702-1707.
13. Chang C.Y., Cook M.B., Lee Y.C., et al. Current status of Barrett's esophagus research in Asia. J Gastroenterol Hepatol 2011, 26:240-246.
14. Lee H.S., Jeon S.W. Barrett esophagus in Asia: same disease with different pattern. Clin Endosc 2014, 47:15-22.
15. Moher D., Liberati A., Tetzlaff J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. W64.
16. Sharma P., Dent J., Armstrong D., et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006, 131:1392-1399.
17. Loney P.L., Chambers L.W., Bennett K.J., et al. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can 1998, 19:170-176.
18. Guyatt G.H., Oxman A.D., Kunz R., et al. GRADE guidelines: 7-rating the quality of evidence: inconsistency. J Clin Epidemiol 2011, 64:1294-1302.
19. Kanwal F., White D. Systematic reviews and meta-analyses in Clinical Gastroenterology and Hepatology. Clin Gastroenterol Hepatol 2012, 10:1184-1186.
20. Akiyama T., Inamori M., Iida H., et al. Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men. BMC Gastroenterol 2008, 8:58.
21. Akiyama T., Inamori M., Akimoto K., et al. Gastric surgery is not a risk factor for the development or progression of Barrett's epithelium. Hepatogastroenterology 2008, 55:1899-1904.
22. Akiyama T., Inamori M., Akimoto K., et al. Gender differences in the age-stratified prevalence of erosive esophagitis and Barrett's epithelium in Japan. Hepatogastroenterology 2009, 56:144-148.
23. Akiyama T., Inamori M., Iida H., et al. Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis. World J Gastroenterol 2010, 16:484-489.
24. Peng S., Xiong L.S., Xiao Y.L., et al. Prompt upper endoscopy is an appropriate initial management in uninvestigated chinese patients with typical reflux symptoms. Am J Gastroenterol 2010, 105:1947-1952.
25. Kim B.C., Yoon Y.H., Jyung H.S., et al. [Clinical characteristics of gastroesophageal reflux diseases and association with Helicobacter pylori infection]. Korean J Gastroenterol 2006, 47:363-369.
26. Zhang M., Fan X.S., Zou X.P. The prevalence of Barrett's esophagus remains low in Eastern China: single-center 7-year descriptive study. Saudi Med J 2012, 33:1324-1329.
27. Yeh C., Hsu C.T., Ho A.S., et al. Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected. Dig Dis Sci 1997, 42:702-706.
28. Lee J.I., Park H., Jung H.Y., et al. Prevalence of Barrett's esophagus in an urban Korean population: a multicenter study. J Gastroenterol 2003, 38:23-27.
29. Toruner M., Soykan I., Ensari A., et al. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms. J Gastroenterol Hepatol 2004, 19:535-540.
30. Rosaida M.S., Goh K.L. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol 2004, 16:495-501.
31. Rajendra S., Kutty K., Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig Dis Sci 2004, 49:237-242.
32. Kim J.Y., Kim Y.S., Jung M.K., et al. Prevalence of Barrett's esophagus in Korea. J Gastroenterol Hepatol 2005, 20:633-636.
33. Ang T.L., Fock K.M., Ng T.M., et al. A comparison of the clinical, demographic and psychiatric profiles among patients with erosive and non-erosive reflux disease in a multi-ethnic Asian country. World J Gastroenterol 2005, 11:3558-3561.
34. Amano Y., Kushiyama Y., Yuki T., et al. Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype. Scand J Gastroenterol 2006, 41:873-879.
35. Yilmaz N., Tuncer K., Tunçyürek M., et al. The prevalence of Barrett's esophagus and erosive esophagitis in a tertiary referral center in Turkey. Turk J Gastroenterol 2006, 17:79-83.
36. Rezailashkajani M., Roshandel D., Shafaee S., et al. High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients. Eur J Gastroenterol Hepatol 2007, 19:499-506.
37. Kim J.H., Rhee P.L., Lee J.H., et al. Prevalence and risk factors of Barrett's esophagus in Korea. J Gastroenterol Hepatol 2007, 22:908-912.
38. Chang C.Y., Lee Y.C., Lee C.T., et al. The application of Prague C and M criteria in the diagnosis of Barrett's esophagus in an ethnic Chinese population. Am J Gastroenterol 2009, 104:13-20.
39. Odemiş B., Ciçek B., Zengin N.I., et al. Barrett's esophagus and endoscopically assessed esophagogastric junction integrity in 1000 consecutive Turkish patients undergoing endoscopy: a prospective study. Dis Esophagus 2009, 22:649-655.
40. Peng S., Cui Y., Xiao Y.L., et al. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population. Endoscopy 2009, 41:1011-1017.
41. Kuo C.J., Lin C.H., Liu N.J., et al. Frequency and risk factors for Barrett's esophagus in Taiwanese patients: a prospective study in a tertiary referral center. Dig Dis Sci 2010, 55:1337-1343.
42. Chen M.J., Lee Y.C., Chiu H.M., et al. Time trends of endoscopic and pathological diagnoses related to gastroesophageal reflux disease in a Chinese population: eight years single institution experience. Dis Esophagus 2010, 23:201-207.
43. Lee I.S., Choi S.C., Shim K.N., et al. Prevalence of Barrett's esophagus remains low in the Korean population: nationwide cross-sectional prospective multicenter study. Dig Dis Sci 2010, 55:1932-1939.
44. Xiong L.S., Cui Y., Wang J.P., et al. Prevalence and risk factors of Barrett's esophagus in patients undergoing endoscopy for upper gastrointestinal symptoms. J Dig Dis 2010, 11:83-87.
45. Mathew P., Joshi A.S., Shukla A., et al. Risk factors for Barrett's esophagus in Indian patients with gastroesophageal reflux disease. J Gastroenterol Hepatol 2011, 26:1151-1156.
46. Lee Y.Y., Tuan Sharif S.E., Syed Abd Aziz S.H., et al. Barrett's esophagus in an area with an exceptionally low prevalence of Helicobacter pylori infection. ISRN Gastroenterol 2011, 2011:394734.
47. Jung H.K., Kim S.E., Shim K.N., et al. [Association between dyspepsia and upper endoscopic findings]. Korean J Gastroenterol 2012, 59:275-281.
48. Zhang R.G., Wang C.S., Gao C.F. Prevalence and pathogenesis of Barrett's esophagus in Luoyang, China. Asian Pac J Cancer Prev 2012, 13:2185-2191.
49. Choi C.Y., Suh S., Park J.S., et al. [The prevalence of Barrett's esophagus and the comparison of Barrett's esophagus with cardiac intestinal metaplasia in the health screening at a secondary care hospital]. Korean J Gastroenterol 2012, 60:219-223.
50. Yin C., Zhang J., Gao M., et al. Epidemiological investigation of Barrett's esophagus in patients with gastroesophageal reflux disease in Northwest China. Journal of Medical Colleges of PLA 2012, 27:187-197.
51. Khamechian T., Alizargar J., Mazoochi T. The prevalence of Barrett's esophagus in outpatients with dyspepsia in Shaheed Beheshti Hospital of Kashan. Iran J Med Sci 2013, 38:263-266.
52. Sharifi A., Dowlatshahi S., Moradi Tabriz H., et al. The prevalence, risk factors, and clinical correlates of erosive esophagitis and Barrett's esophagus in Iranian patients with reflux symptoms. Gastroenterol Res Pract 2014, 2014:696294.
53. Azuma N., Endo T., Arimura Y., et al. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan. J Gastroenterol 2000, 35:583-592.
54. Choi D.W., Oh S.N., Baek S.J., et al. Endoscopically observed lower esophageal capillary patterns. Korean J Intern Med 2002, 17:245-248.
55. Nasseri-Moghaddam S., Malekzadeh R., Sotoudeh M., et al. Lower esophagus in dyspeptic Iranian patients: a prospective study. J Gastroenterol Hepatol 2003, 18:315-321.
56. Hongo M., Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol 2003, 38(Suppl 15):25-30.
57. Fujiwara Y., Higuchi K., Shiba M., et al. Association between gastroesophageal flap valve, reflux esophagitis, Barrett's epithelium, and atrophic gastritis assessed by endoscopy in Japanese patients. J Gastroenterol 2003, 38:533-539.
58. Khalaf A.S. The efficacy of endoscopy: analysis of its use in the evaluation of dyspeptic patients in Qatar. Emirates Medical Journal 2003, 21:134-138.
59. Kawano T., Kouzu T., Ohara S., et al. The prevalence of Barrett's mucosa in the Japanese. Gastroenterological Endoscopy 2005, 47:951-961.
60. Wang W., Zhang Z.J., Lin K.R., et al. [The prevalence, clinical and endoscopic characteristics of Barrett esophagus in Fujian]. Zhonghua Nei Ke Za Zhi 2006, 45:393-395.
61. Yoo S.S., Lee W.H., Ha J., et al. [The prevalence of esophageal disorders in the subjects examined for health screening]. Korean J Gastroenterol 2007, 50:306-312.
62. Tseng P.H., Lee Y.C., Chiu H.M., et al. Prevalence and clinical characteristics of Barrett's esophagus in a Chinese general population. J Clin Gastroenterol 2008, 42:1074-1079.
63. Yamagishi H., Koike T., Ohara S., et al. Tongue-like Barrett's esophagus is associated with gastroesophageal reflux disease. World J Gastroenterol 2008, 14:4196-4203.
64. Kim J.H., Hwang J.K., Kim J., et al. Endoscopic findings around the gastroesophageal junction: an experience from a tertiary hospital in Korea. Korean J Intern Med 2008, 23:127-133.
65. Okita K., Amano Y., Takahashi Y., et al. Barrett's esophagus in Japanese patients: its prevalence, form, and elongation. J Gastroenterol 2008, 43:928-934.
66. Park J.J., Kim J.W., Kim H.J., et al. The prevalence of and risk factors for Barrett's esophagus in a Korean population: a nationwide multicenter prospective study. J Clin Gastroenterol 2009, 43:907-914.
67. Shi X., Wang L., Hao H., et al. Study on reflux esophagitis, Barrett's esophagus and esophageal adenocarcinoma. Chin J Gastroenterology 2010, 15:233-236.
68. Zou D., He J., Ma X., et al. Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the systematic investigation of gastrointestinal diseases in China (SILC). Scand J Gastroenterol 2011, 46:133-141.
69. Fujimoto A., Hoteya S., Iizuka T., et al. Obesity and gastrointestinal diseases. Gastroenterol Res Pract 2013, 2013:760574.
70. Watari J., Hori K., Toyoshima F., et al. Association between obesity and Barrett's esophagus in a Japanese population: a hospital-based, cross-sectional study. BMC Gastroenterol 2013, 13:143.
71. Yin X., Xu Y.-L., Zhou J., et al. Relationship among symptoms, endoscopic classification and pathological characteristics of Barrett esophagus. Journal of Shanghai Jiaotong University (Medical Science) 2013, 33:50-55.
72. Ronkainen J., Aro P., Storskrubb T., et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005, 129:1825-1831.
73. Gerson L.B., Edson R., Lavori P.W., et al. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol 2001, 96:2005-2012.
74. Malfertheiner P., Lind T., Willich S., et al. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study. Gut 2005, 54:746-751.
75. Vakil N., van Zanten S.V., Kahrilas P., et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006, 101:1900-1920. quiz 43.
76. Harrison R., Perry I., Haddadin W., et al. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol 2007, 102:1154-1161.
77. O'Connor J.B., Falk G.W., Richter J.E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 1999, 94:2037-2042.
78. Lao C.D., Simmons M., Syngal S., et al. Dysplasia in Barrett esophagus. Cancer 2004, 100:1622-1627.
79. Fan X., Snyder N. Prevalence of Barrett's esophagus in patients with or without GERD symptoms: role of race, age, and gender. Dig Dis Sci 2009, 54:572-577.
80. Wani S. Population-based estimates of cancer and mortality in Barrett's esophagus: implications for the future. Clin Gastroenterol Hepatol 2011, 9:723-724.
81. Rubenstein J.H., Morgenstern H., Appelman H., et al. Prediction of Barrett's esophagus among men. Am J Gastroenterol 2013, 108:353-362.
82. Lee Y.C., Cook M.B., Bhatia S., et al. Interobserver reliability in the endoscopic diagnosis and grading of Barrett's esophagus: an Asian multinational study. Endoscopy 2010, 42:699-704.
83. Cook M.B., Wild C.P., Forman D. A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol 2005, 162:1050-1061.
84. Andrici J., Tio M., Cox M.R., et al. Hiatal hernia and the risk of Barrett's esophagus. J Gastroenterol Hepatol 2013, 28:415-431.
85. Andrici J., Cox M.R., Eslick G.D. Cigarette smoking and the risk of Barrett's esophagus: a systematic review and meta-analysis. J Gastroenterol Hepatol 2013, 28:1258-1273.
86. Cook M.B., Greenwood D.C., Hardie L.J., et al. A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. Am J Gastroenterol 2008, 103:292-300.
87. Spechler S.J., Souza R.F. Barrett's esophagus. N Engl J Med 2014, 371:836-845.
88. Fischbach L.A., Nordenstedt H., Kramer J.R., et al. The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter 2012, 17:163-175.
89. Shaheen N.J., Crosby M.A., Bozymski E.M., et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology 2000, 119:333-338.
90. Goda K., Singh R., Oda I., et al. Current status of endoscopic diagnosis and treatment of superficial Barrett's adenocarcinoma in Asia-Pacific region. Dig Endosc 2013, 25(Suppl 2):146-150.